CSIMarket
 
Nrx Pharmaceuticals Inc   (NASDAQ: NRXP)
 

Nrx Pharmaceuticals Inc's Customers Performance

NRXP



 
NRXP's Source of Revenues During the corresponding time, Nrx Pharmaceuticals Inc sequentially revenue grew by 3.09 %. While revenue at the Nrx Pharmaceuticals Inc 's corporate clients

List of NRXP Customers




for the same period Nrx Pharmaceuticals Inc sequentially revenue grew by 3.09 %.

List of NRXP Customers

Nrx Pharmaceuticals Inc's Business Units
Therapy    148.23 % of total Revenue






Nrx Pharmaceuticals Inc's Comment on Sales, Marketing and Customers



The company’s customers primarily include Federal healthcare programs, such as drug manufacturers that bill these programs for their products. The company addresses issues related to marketing products for unapproved uses and reporting drug pricing information to Federal healthcare programs. Compliance with laws including the False Claims Act, the Health Insurance Portability and Accountability Act (HIPAA), and the Veterans Health Care Act is also emphasized. Market segments served include Federal healthcare programs, private third-party payers, Medicaid, other state programs, and the Federal Supply Schedule for covered drugs.





Nrx Pharmaceuticals Inc’s Comment on Sales, Marketing and Customers


The company’s customers primarily include Federal healthcare programs, such as drug manufacturers that bill these programs for their products. The company addresses issues related to marketing products for unapproved uses and reporting drug pricing information to Federal healthcare programs. Compliance with laws including the False Claims Act, the Health Insurance Portability and Accountability Act (HIPAA), and the Veterans Health Care Act is also emphasized. Market segments served include Federal healthcare programs, private third-party payers, Medicaid, other state programs, and the Federal Supply Schedule for covered drugs.








NRXP's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Nrx Pharmaceuticals Inc 128.01 0.00 -23.52 29
SUBTOTAL 0.00 0.00 0.00 -

Sources: Nrx Pharmaceuticals Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Nrx Pharmaceuticals Inc’s corporate clients.
For your research, we’ve provided 9 tables on Nrx Pharmaceuticals Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.